Makoto Nishida Selected Research

Makoto Nishida Research Topics

Disease

17	Atherosclerosis 10/2019 - 11/2002
10	Inflammation (Inflammations) 10/2019 - 09/2007
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2016 - 12/2006
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2007
8	Hypertriglyceridemia 02/2022 - 05/2009
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017 - 02/2003
7	Hyperlipidemias (Hyperlipidemia) 09/2012 - 04/2008
6	Fibrosis (Cirrhosis) 01/2022 - 09/2007
5	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2013
5	Obesity 08/2012 - 05/2002
4	Proteinuria 01/2021 - 03/2012
4	Dyslipidemias (Dyslipidemia) 06/2018 - 05/2009
4	Neoplasms (Cancer) 06/2016 - 06/2007
3	Myocardial Infarction 02/2022 - 01/2013
3	Heart Failure 01/2021 - 01/2013
3	Tangier Disease 10/2018 - 06/2007
3	Hypertension (High Blood Pressure) 10/2013 - 09/2007
3	Platelet Glycoprotein IV Deficiency 01/2012 - 05/2009
3	Coronary Disease (Coronary Heart Disease) 09/2011 - 12/2009
2	Hypertrophy 01/2022 - 09/2007
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2021 - 01/2012
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2019
2	Cholesteryl Ester Transfer Protein Deficiency 03/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 06/2018 - 09/2007
2	Hyperglycemia 06/2018 - 05/2009
2	Body Weight (Weight, Body) 02/2018 - 06/2007
2	Insulin Resistance 12/2012 - 06/2007
2	Xanthomatosis (Xanthoma) 09/2010 - 08/2005
2	Hypoadiponectinemia 10/2007 - 10/2002
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2022
1	Fatty Liver 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020
1	Lymphoma (Lymphomas) 11/2020
1	Hypoxia (Hypoxemia) 10/2019
1	Coronary Occlusion 10/2019
1	Acute-Phase Reaction 03/2019
1	Vitiligo 01/2019

Drug/Important Bio-Agent (IBA)

16	AdiponectinIBA 09/2016 - 05/2002
10	CholesterolIBA 01/2022 - 08/2005
10	HDL LipoproteinsIBA 03/2019 - 08/2005
10	Lipoproteins (Lipoprotein)IBA 06/2018 - 05/2009
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2007
7	HDL CholesterolIBA 03/2019 - 06/2007
7	Apolipoprotein B-48IBA 01/2014 - 01/2011
7	oxidized low density lipoproteinIBA 01/2014 - 12/2009
6	Triglycerides (Triacylglycerol)IBA 02/2018 - 06/2007
4	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 02/2022 - 02/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2011
4	CytokinesIBA 01/2018 - 10/2007
4	Interleukin-6 (Interleukin 6)IBA 02/2015 - 09/2007
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2008 - 08/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2002
3	Hormones (Hormone)IBA 09/2016 - 05/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 06/2002
3	Chylomicron RemnantsIBA 01/2014 - 05/2009
3	ApolipoproteinsIBA 01/2014 - 11/2002
3	ChylomicronsIBA 01/2014 - 09/2011
3	LDL CholesterolIBA 09/2010 - 06/2007
3	C-Reactive ProteinIBA 10/2007 - 02/2003
2	Probucol (Lorelco)FDA Link 07/2021 - 01/2012
2	Complement System Proteins (Complement)IBA 01/2020 - 03/2019
2	ProgranulinsIBA 01/2020 - 10/2013
2	Cholesterol Ester Transfer ProteinsIBA 03/2019 - 01/2018
2	LipidsIBA 03/2019 - 11/2005
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 09/2010
2	Fenofibrate (CiL)FDA LinkGeneric 02/2018 - 06/2010
2	InterleukinsIBA 01/2018 - 09/2015
2	fibroblast growth factor 21IBA 01/2018 - 09/2015
2	ChemokinesIBA 02/2015 - 03/2013
2	ORALIT (ORS)IBA 10/2013 - 07/2011
2	Testosterone (Sustanon)FDA Link 10/2013 - 01/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2010 - 06/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010 - 05/2010
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2010 - 06/2009
2	Ezetimibe (Zetia)FDA Link 09/2010 - 09/2010
2	TetraspaninsIBA 01/2009 - 07/2008
1	Inosine Triphosphate (ITP)IBA 02/2022
1	SteroidsIBA 02/2022
1	InflammasomesIBA 01/2022
1	Pharmaceutical PreparationsIBA 07/2021
1	7-ketocholesterolIBA 01/2020
1	CateninsIBA 01/2020
1	Proteinase-Activated ReceptorsIBA 10/2019
1	RivaroxabanIBA 10/2019
1	CoagulantsIBA 10/2019
1	Peptide Hydrolases (Proteases)FDA Link 03/2019
1	ProteomeIBA 03/2019
1	Apolipoprotein C-IIIIBA 03/2019
1	AutoantibodiesIBA 01/2019
1	rhododendrolIBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 06/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2018
1	ProstaglandinsIBA 12/2017
1	high density lipoprotein receptorsIBA 12/2017

Therapy/Procedure

3	Therapeutics 02/2022 - 09/2010
2	Ligation 10/2019 - 01/2013
2	Drug Therapy (Chemotherapy) 06/2016 - 09/2010
1	Organ Transplantation 11/2020
1	Kidney Transplantation 11/2020
1	Glycemic Control 06/2018